Previous Close | 8.30 |
Open | 8.45 |
Bid | 8.10 x 1000 |
Ask | 8.13 x 200 |
Day's Range | 8.10 - 8.45 |
52 Week Range | 7.53 - 15.70 |
Volume | |
Avg. Volume | 4,589,581 |
Market Cap | 1.291B |
Beta (5Y Monthly) | 0.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
Shares of Ironwood Pharmaceuticals collapsed Thursday on mixed results for its gastrointestinal drug. The biotech stock erased a 38% gain.